Epify BV
Facilitating cancer diagnosis and personalized treatments through epigenetic biomarkers.
The Netherlands
1 employees
Seed
Total: $500.00K
Biotechnology, Health Care +1
General Information
The Netherlands
BounceWatch is an independent company data service, not affiliated with Epify BV. To contact Epify BV, visit epify.nl.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Epify BV compare?
A PDF of Epify BV and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Epify BV soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
The Netherlands Market
Biotechnology
About Epify BV
Business keywords: Epigenetic biomarkers, Cancer diagnosis, Personalized treatments, Oncology, Early detection, Accurate diagnosis, Cancer patients, Maastricht University, Ghent University, Bioinformatics, Industrial applications, Scientific expertise, Business knowledge, Biomarker accessibility
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | €500.00K | - |
|
26 Sep 2019 |
Epify BV Alternatives & Competitors
View All Alternatives
Addressing a critical need to find cancer early and treat cancer at the cellular level.
Leading the world in early cancer detection research.
LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analysis of biom...
FAQ About Epify BV
Source: BounceWatch company record for Epify BV, https://bouncewatch.com/company/epify, updated 27 October 2024. When citing, please name BounceWatch and link this page.
